Bamrasnadura Institute Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2009
NCT01014481
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Alternative names

Bamrasnaradura Infectious Diseases Institute, Ministry of Public Health, Nonthaburi, Thailand

Active Ingredients

Drugs in Phase 4 Trials (3)

efavirenz (sustiva) (1 trial)

lamivudine (epivir) (1 trial)

tenofovir (viread) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Tuberculosis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 3